- Home
- BNC vs ACIU Comparison
BNC vs ACIU Comparison
Compare BNC & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BNC | ACIU |
|---|---|---|
| Founded | N/A | 2003 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 287.3M | 247.6M |
| IPO Year | 2010 | 2015 |
Fundamental Metrics
Financial Performance| Metric | BNC | ACIU |
|---|---|---|
| Price | $5.33 | $2.41 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $8.57 |
| AVG Volume (30 Days) | ★ 835.4K | 182.8K |
| Earning Date | 09-11-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 159.72 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,581,968.00 | N/A |
| Revenue This Year | $27.15 | $422.39 |
| Revenue Next Year | $6.70 | $377.85 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 32.89 | N/A |
| 52 Week Low | $1.84 | $2.10 |
| 52 Week High | $7.99 | $4.00 |
Technical Indicators
Market Signals| Indicator | BNC | ACIU |
|---|---|---|
| Relative Strength Index (RSI) | 52.72 | 42.07 |
| Support Level | $2.15 | $2.40 |
| Resistance Level | $5.58 | $2.68 |
| Average True Range (ATR) | 0.25 | 0.09 |
| MACD | -0.06 | -0.00 |
| Stochastic Oscillator | 55.24 | 18.92 |
Price Performance
Historical ComparisonAbout BNC CEA Industries Inc.
CEA Industries Inc through its subsidiary is focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture ("CEA") industry. The company provides integrated mechanical, electrical, and plumbing ("MEP") engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. The Company has one operating segment that is dedicated to the manufacture and sale of its products.
About ACIU AC Immune SA
AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.